Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat Heart
Open accessAbstract
Obesity is associated with risk factors for cardiovascular disease, including insulin resistance, and can lead to cardiac hypertrophy and congestive heart failure. Here, we used the insulin-sensitizing agent rosiglitazone to investigate the cellular mechanisms linking insulin resistance in the obese Zucker rat heart with increased susceptibility to ischemic injury. Rats were treated for 7 or 14 days with 3 mg/kg per os rosiglitazone. Hearts were isolated and perfused before and during insulin stimulation or during 32 min low-flow ischemia at 0.3 ml · min−1 · grams wet wt−1 and reperfusion. d[2-3H]glucose was used as a tracer of glucose uptake, and phosphorus-31 nuclear magnetic resonance spectroscopy was used to follow energetics during ischemia. At 12 months of age, obese rat hearts were insulin resistant with decreased GLUT4 protein expression. During ischemia, glucose uptake was lower and depletion of ATP was greater in obese rat hearts, thereby significantly impairing recovery of contractile function during reperfusion. Rosiglitazone treatment normalized the insulin resistance and restored GLUT4 protein levels in obese rat hearts. Glucose uptake during ischemia was also normalized by rosiglitazone treatment, thereby preventing the greater loss of ATP and restoring recovery of contractile function to that of lean rat hearts. We conclude that rosiglitazone treatment, by normalizing glucose uptake, protected obese rat hearts from ischemic injury.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies in older Zucker rats demonstrated reduced recovery from ischemia, which could be prevented by treating these animals with a TZD.
“In contrast, studies in older Zucker rats demonstrated reduced recovery from ischemia, which could be prevented by treating these animals with a TZD (159, 322, 389).”
From Cardiac remodeling in obesity (2008) · cites this paper as [322]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · see citing works
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956 · see citing works
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730 · see citing works
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · see citing works
Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · see citing works
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265 · see citing works
Vidal‐Puig, A., Considine, R. V., Jimenez‐Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 785 · see citing works
Friedman, J. M. (2000) · Nature · doi:10.1038/35007504 · Cited by 701 · see citing works
Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10843 · Cited by 536 · see citing works
Goodyear, L. J., Giorgino, F., Sherman, L., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 525 · see citing works
Enzymatic analysis; a practical guide
(1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90404-l · Cited by 522 · see citing works
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diabetes.46.1.3 · Cited by 479 · see citing works
Yet, S., Tian, R., Layne, M. D., Wang, Z. Y., Maemura, K., Solovyeva, M., Ith, B., Melo, L. G., Zhang, L., Ingwall, J. S., et al. (2001) · Circulation Research · doi:10.1161/hh1401.093314 · Cited by 420 · see citing works
Protons in ischemia: Where do they come from; Where do they go to?
Dennis, S. C. (1991) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(91)91642-5 · Cited by 344 · see citing works
Troglitazone action is independent of adipose tissue.
Burant, C., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J. J., Lukens, J. N., Davidson, N. O., Ross, S. R., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 333 · see citing works
Gastaldelli, A., Baldi, S., Pettiti, M., Toschi, E., Camastra, S., Natali, A., Landau, B. R., & Ferrannini, E. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1367 · Cited by 320 · see citing works
Passonneau, J. V., & Lowry, O. H. (1993) · Humana Press eBooks · doi:10.1007/978-1-60327-407-4 · Cited by 300 · see citing works
Yue, T.-L., Chen, J., Bao, W., Narayanan, P. K., Bril, A., Jiang, W., Lysko, P. G., Gu, J.-L., Boyce, R., Zimmerman, D. M., et al. (2001) · Circulation · doi:10.1161/hc4601.099403 · Cited by 295 · see citing works
Self-citationKanai, F., Ito, K., Todaka, M., Hayashi, H., Kamohara, S., Ishii, K., Okada, T., Hazeki, O., Ui, M., & Ebina, Y. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2111 · Cited by 281 · see citing works
Responses of GLUT4-Deficient Hearts to Ischemia Underscore the Importance of Glycolysis
Tian, R., & Abel, E. D. (2001) · Circulation · doi:10.1161/01.cir.103.24.2961 · Cited by 233 · see citing works
Oakes, N. D., Kennedy, C. J., Jenkins, A. B., Laybutt, D. R., Chisholm, D. J., & Kraegen, E. W. (1994) · Diabetes · doi:10.2337/diab.43.10.1203 · Cited by 224 · see citing works
Anai, M., Funaki, M., Ogihara, T., Terasaki, J., Inukai, K., Katagiri, H., Fukushima, Y., Yazaki, Y., Kikuchi, M., Oka, Y., et al. (1998) · Diabetes · doi:10.2337/diab.47.1.13 · Cited by 180 · see citing works
Loviscach, M., Rehman, N., Carter, L., Mudaliar, S. R. D., Mohadeen, P., Ciaraldi, T. P., Veerkamp, J. H., & Henry, R. R. (2000) · Diabetologia · doi:10.1007/s001250050048 · Cited by 176 · see citing works
Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts.
Owen, P., Dennis, S. C., & Opie, L. H. (1990) · Circulation Research · doi:10.1161/01.res.66.2.344 · Cited by 175 · see citing works
Is a High Glycogen Content Beneficial or Detrimental to the Ischemic Rat Heart?
Cross, H. R., Opie, L. H., Radda, G. K., & Clarke, K. (1996) · Circulation Research · doi:10.1161/01.res.78.3.482 · Cited by 168 · see citing works
Self-citationKim, H. I., Kim, J. W., Kim, S. H., Cha, J.-Y., Kim, K., & Ahn, Y. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1517 · Cited by 119 · see citing works
Regulation of GLUT4 Gene Expression by Arachidonic Acid
Long, S. D., & Pekala, P. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1138 · Cited by 112 · see citing works
The missing link with obesity?
Flier, J. S. (2001) · Nature · doi:10.1038/35053251 · Cited by 109 · see citing works
Tong, H., Chen, W., London, R. E., Murphy, E., & Steenbergen, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11981 · Cited by 91 · see citing works
Troglitazone Improves Recovery of Left Ventricular Function After Regional Ischemia in Pigs
Zhu, P., Li, L., Xu, Y., & Schwartz, G. G. (2000) · Circulation · doi:10.1161/01.cir.101.10.1165 · Cited by 90 · see citing works
Cross, H. R., Clarke, K., Opie, L. H., & Radda, G. K. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1995.0130 · Cited by 82 · see citing works
Self-citationKitamura, Y., Kakimura, J., Matsuoka, Y., Nomura, Y., Gebicke‐Haerter, P. J., & Taniguchi, T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00055-5 · Cited by 81 · see citing works
Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats
Kolter, T., Uphues, I., & Eckel, J. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.1.e59 · Cited by 78 · see citing works
King, L. M., & Opie, L. H. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00100-x · Cited by 75 · see citing works
Egert, S. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00133-8 · Cited by 75 · see citing works
McCune, S. A., Durant, P. J., Jenkins, P. A., & Harris, R. A. (1981) · Metabolism · doi:10.1016/0026-0495(81)90037-8 · Cited by 70 · see citing works
Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes
Bähr, M., Spelleken, M., Bock, M., von Holtey, M., Kiehn, R., & Eckel, J. (1996) · Diabetologia · doi:10.1007/s001250050509 · Cited by 70 · see citing works
Anai, M., Funaki, M., Ogihara, T., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.1.13 · Cited by 62 · see citing works
Uphues, I., Kolter, T., Goud, B., & Eckel, J. (1995) · Biochemical Journal · doi:10.1042/bj3110161 · Cited by 59 · see citing works
α-Adrenergic Stimulation Mediates Glucose Uptake Through Phosphatidylinositol 3-Kinase in Rat Heart
Doenst, T., & Taegtmeyer, H. (1999) · Circulation Research · doi:10.1161/01.res.84.4.467 · Cited by 56 · see citing works
Cellular and molecular regulation of cardiac glucose transport
Young, L. H., Coven, D. L., & Russell, R. R. (2000) · Journal of Nuclear Cardiology · doi:10.1016/s1071-3581(00)70016-x · Cited by 55 · see citing works
Müller, C., Assimacopoulos‐Jeannet, F., Mosimann, F., Schneiter, P., Riou, J. P., Pachiaudi, C., Felber, J. P., Jéquier, E., Jeanrenaud, B., & Tappy, L. (1997) · Diabetologia · doi:10.1007/s001250050701 · Cited by 53 · see citing works
Protection of ischemic hearts by high glucose is mediated, in part, by GLUT-4
Ramasamy, R., Hwang, Y. C., Whang, J., & Bergmann, S. R. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h290 · Cited by 50 · see citing works
Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats
Shimabukuro, M., Higa, S., Shinzato, T., Nagamine, F., Komiya, I., & Takasu, N. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90018-9 · Cited by 43 · see citing works
Cardiovascular abnormalities associated with human and rodent obesity
Paulson, D. J., & Tahiliani, A. G. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90618-y · Cited by 40 · see citing works
The New Antidiabetic Drug MCC-555 Acutely Sensitizes Insulin Signaling in Isolated Cardiomyocytes
Liu, L. S., Tanaka, H., Ishii, S., & Eckel, J. (1998) · Endocrinology · doi:10.1210/endo.139.11.6310 · Cited by 38 · see citing works
Wang, P. H., Almahfouz, A., Giorgino, F., McCowen, K. C., & Smith, R. J. (1999) · Endocrinology · doi:10.1210/endo.140.3.6595 · Cited by 32 · see citing works
Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia
King, L. M., Sidell, R. J., Wilding, J. R., Radda, G. K., & Clarke, K. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.3.h1173 · Cited by 30 · see citing works
Self-citationZaninetti, D., Greco-Perotto, R., Assimacopoulos‐Jeannet, F., & Jeanrenaud, B. (1989) · Diabetologia · doi:10.1007/bf00265405 · Cited by 24 · see citing works
Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats
Gennaro-Colonna, V. D., Rossoni, G., Cocchi, D., Rigamonti, A. E., Berti, F., & Ee, M. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660529 · Cited by 22 · see citing works
Isolated Hearts from Obese Rats Show Impaired Function during Hypoxia
Segel, L. D., Rendig, S. V., Mason, D. T., & Stern, J. S. (1980) · Experimental Biology and Medicine · doi:10.3181/00379727-163-40731 · Cited by 14 · see citing works
Rosiglitazone prevents ischaemic injury in the obese Zucker rat heart
Sidell, R. J., Cole, M. A., Draper, N., Clarke, K., & Buckingham, R. E. (2001) · Diabetologia · Cited by 3 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,180 · see citing works
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543 · see citing works
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Kolwicz, S. C., Purohit, S., & Tian, R. (2013) · Circulation Research · doi:10.1161/circresaha.113.302095 · Cited by 810 · see citing works
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736 · see citing works
Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 567 · see citing works
Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes
Scheuermann-Freestone, M., Madsen, P. L., Manners, D., Blamire, A. M., Buckingham, R. E., Styles, P., Radda, G. K., Neubauer, S., & Clarke, K. (2003) · Circulation · doi:10.1161/01.cir.0000072789.89096.10 · Cited by 525 · see citing works
Self-citationFillmore, N., Mori, J., & Lopaschuk, G. D. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12475 · Cited by 465 · see citing works
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
An, D., & Rodrigues, B. B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00278.2006 · Cited by 443 · see citing works
Mazumder, P. K., O’Neill, B. T., Roberts, M. W., Buchanan, J., Yun, U. J., Cooksey, R. C., Boudina, S., & Abel, E. D. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2366 · Cited by 437 · see citing works
Jaswal, J. S., Keung, W., Wang, W., Ussher, J. R., & Lopaschuk, G. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.015 · Cited by 396 · see citing works
Peroxisome Proliferator-Activated Receptors
Schiffrin, E. L., Amiri, F., Benkirane, K., Iglarz, M., & Diep, Q. N. (2003) · Hypertension · doi:10.1161/01.hyp.0000084370.74777.b6 · Cited by 369 · see citing works
Insulin-Resistant Cardiomyopathy
Witteles, R. M., & Fowler, M. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.021 · Cited by 349 · see citing works
Taegtmeyer, H., Young, M. E., Lopaschuk, G. D., Abel, E. D., Brunengraber, H., Darley-Usmar, V. M., Rosiers, C. D., Gerszten, R. E., Glatz, J. F. C., Griffin, J. L., et al. (2016) · Circulation Research · doi:10.1161/res.0000000000000097 · Cited by 283 · see citing works
Aasum, E., Hafstad, A. D., Severson, D. L., & Larsen, T. S. (2003) · Diabetes · doi:10.2337/diabetes.52.2.434 · Cited by 280 · see citing works
Huang, T. H.-W., PENG, G., Kota, B. P., Li, G. Q., YAMAHARA, J., Roufogalis, B. D., & Li, Y. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.12.009 · Cited by 276 · see citing works
Glucose Transporters in Cardiac Metabolism and Hypertrophy
Shao, D., & Tian, R. (2015) · Comprehensive physiology · doi:10.1002/cphy.c150016 · Cited by 273 · see citing works
Endothelial function, inflammation, and prognosis in cardiovascular disease
Gonzalez, M. A., & Selwyn, A. P. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.016 · Cited by 258 · see citing works
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Cai, W., Yang, T., Liu, H., Han, L., Zhang, K., Hu, X., Zhang, X., Yin, K., Gao, Y., Bennett, M. V. L., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.002 · Cited by 238 · see citing works
Involvement of PPAR nuclear receptors in tissue injury and wound repair
Michalik, L. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27958 · Cited by 236 · see citing works
The PPAR regulatory system in cardiac physiology and disease
Finck, B. N. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.08.023 · Cited by 222 · see citing works
Cole, M. A., Murray, A. J., Cochlin, L. E., Heather, L. C., McAleese, S., Knight, N. S., Sutton, E. R., Jamil, A. H. A., Parassol, N., & Clarke, K. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0156-1 · Cited by 190 · see citing works
Self-citationWagstaff, A. J., & Goa, K. L. (2002) · Drugs · doi:10.2165/00003495-200262120-00007 · Cited by 175 · see citing works
Yue, T.-L., Bao, W., Gu, J.-L., Cui, J., Tao, L., Ma, X.-L., Ohlstein, E. H., & Jucker, B. M. (2005) · Diabetes · doi:10.2337/diabetes.54.2.554 · Cited by 170 · see citing works
Minireview: Challenges and Opportunities in Development of PPAR Agonists
Wright, M. B., Bortolini, M., Tadayyon, M., & Bopst, M. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1427 · Cited by 169 · see citing works
Metabolic remodelling in diabetic cardiomyopathy
Chong, C., Clarke, K., & Levelt, E. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx018 · Cited by 154 · see citing works
Self-citationChung, Y. J., Park, K. C., Tokar, S., Eykyn, T. R., Fuller, W., Pavlović, D., Swietach, P., & Shattock, M. J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa323 · Cited by 145 · see citing works
Bertrand, L., Ginion, A., Beauloye, C., Hebert, A. D., Guigas, B., Hue, L., & Vanoverschelde, J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01269.2005 · Cited by 144 · see citing works
Mansor, L. S., Gonzalez, E. R., Cole, M. A., Tyler, D. J., Beeson, J. H., Clarke, K., Carr, C. A., & Heather, L. C. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-136 · Cited by 144 · see citing works
Self-citationSivarajah, A., Chatterjee, P. K., Patel, N. S. A., Todorović, Z., Hattori, Y., Brown, P. A., Stewart, K. N., Mota‐Filipe, H., Cuzzocrea, S., & Thiemermann, C. (2003) · American Journal of Nephrology · doi:10.1159/000072088 · Cited by 144 · see citing works
Targeting mitochondrial oxidative metabolism as an approach to treat heart failure
Fillmore, N., & Lopaschuk, G. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.014 · Cited by 143 · see citing works
Murray, A. J., Panagia, M., Hauton, D., Gibbons, G. F., & Clarke, K. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3496 · Cited by 134 · see citing works
Self-citationMetabolism, hypoxia and the diabetic heart
Heather, L. C., & Clarke, K. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.01.007 · Cited by 131 · see citing works
Self-citationRobinson, E., & Grieve, D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.003 · Cited by 130 · see citing works
Guo, L., & Tabrizchi, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.009 · Cited by 117 · see citing works
Desrois, M. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.021 · Cited by 117 · see citing works
Self-citationLekli, I., Szabó, G. V., Juhász, B., Das, S., Das, M., Varga, E., Szendrei, L., Gesztelyi, R., Váradi, J., Bak, I., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01048.2007 · Cited by 113 · see citing works
Li, Y., Qi, Y., Huang, T. H.-W., Yamahara, J., & Roufogalis, B. D. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00708.x · Cited by 113 · see citing works
Peroxisome proliferator-activated receptors and cardiovascular remodeling
Schiffrin, E. L. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00677.2004 · Cited by 110 · see citing works
Golfman, L. S., Wilson, C. R., Sharma, S., Burgmaier, M., Young, M. E., Guthrie, P. H., Van Arsdall, M., Adrogue, J. V., Brown, K. K., & Taegtmeyer, H. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00055.2005 · Cited by 99 · see citing works
Coort, S. L., Bonen, A., Vusse, G. J., Glatz, J. F. C., & Luiken, J. J. F. P. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9030-5 · Cited by 99 · see citing works
Läutamaki, R., Airaksinen, J. K. E., Seppänen, M., Toikka, J., Luotolahti, M., Ball, E., Borra, R., Härkönen, R., Iozzo, P., Stewart, M. W., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2787 · Cited by 98 · see citing works
Heather, L. C., Catchpole, A., Stuckey, D. J., Cole, M. A., Carr, C. A., & Clarke, K. J. (2009) · PubMed · Cited by 97 · see citing works
Self-citationCarley, A. N., Semeniuk, L. M., Shimoni, Y., Aasum, E., Larsen, T. S., Berger, J. P., & Severson, D. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00329.2003 · Cited by 94 · see citing works
Insulin signaling in the heart
Abel, E. D. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00158.2021 · Cited by 94 · see citing works
Heart Failure as a Multiple Hormonal Deficiency Syndrome
Saccà, L. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.821892 · Cited by 94 · see citing works
García‐Bueno, B., Caso, J. R., Perez‐Nievas, B. G., Lorenzo, P. L., & Leza, J. C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301252 · Cited by 90 · see citing works
Hällsten, K., Virtanen, K. A., Lönnqvist, F., Janatuinen, T., Turiceanu, M., Rönnemaa, T., Viikari, J. S. A., Lehtimäki, T. J., Knuuti, J. M., & Nuutila, P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01332.x · Cited by 89 · see citing works
Lygate, C. A. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00289-x · Cited by 89 · see citing works
Sphingolipids, Lipotoxic Cardiomyopathy, and Cardiac Failure
Park, T., & Goldberg, I. J. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.003 · Cited by 82 · see citing works
Ghaboura, N., Tamareille, S., Ducluzeau, P., Grimaud, L., Loufrani, L., Croué, A., Tourmen, Y., Henrion, D., Furber, A., & Prunier, F. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0130-3 · Cited by 80 · see citing works
Hafstad, A. D., Khalid, A. M., How, O.-J., Larsen, T. S., & Aasum, E. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00504.2006 · Cited by 79 · see citing works
Desrois, M. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.014 · Cited by 77 · see citing works
Self-citationPanagia, M., Gibbons, G. F., Radda, G. K., & Clarke, K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2004 · Cited by 75 · see citing works
Self-citationCole, M. A., Jamil, A. H. A., Heather, L. C., Murray, A. J., Sutton, E. R., Slingo, M., Sebag‐Montefiore, L., Tan, S. C., Aksentijević, D., Gildea, O. S., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201500094r · Cited by 71 · see citing works
Self-citationIncreased basal coronary blood flow as a cause of reduced coronary flow reserve in diabetic patients
Picchi, A., Limbruno, U., Focardi, M., Cortese, B., Micheli, A., Boschi, L., Severi, S., & Caterina, R. D. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00615.2011 · Cited by 70 · see citing works
Gonon, A. T., Bulhak, A., Labruto, F., Sjöquist, P.-O. B., & Pernow, J. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0613-4 · Cited by 67 · see citing works
PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty
Huang, J. V., Greyson, C. R., & Schwartz, G. G. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024505 · Cited by 67 · see citing works
The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity
Karwi, Q. G., Sun, Q., & Lopaschuk, G. D. (2021) · Cells · doi:10.3390/cells10113259 · Cited by 65 · see citing works
Regulation and dysregulation of glucose transport in cardiomyocytes
Montessuit, C., & Lerch, R. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.009 · Cited by 64 · see citing works
Hockings, P. D., Changani, K. K., Saeed, N., Reid, D. G., Birmingham, J. M., O'Brien, P. J., Osborne, J. A., Toseland, C. D. N., & Buckingham, R. E. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00268.x · Cited by 63 · see citing works
Self-citationAasum, E., Khalid, A. M., Gudbrandsen, O. A., How, O.-J., Berge, R. K., & Larsen, T. S. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.020 · Cited by 62 · see citing works
Heart Failure and Loss of Metabolic Control
Wang, Z. V., Li, D. ‘., & Hill, J. A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000054 · Cited by 62 · see citing works
Murray, A. J., Lygate, C. A., Cole, M. A., Carr, C. W., Radda, G. K., Neubauer, S., & Clarke, K. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.031 · Cited by 62 · see citing works
Self-citationPioglitazone Mimics Preconditioning in the Isolated Perfused Rat Heart
Wynne, A. M., Mocanu, M. M., & Yellon, D. M. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000188365.07635.57 · Cited by 60 · see citing works
Targeting metabolic disturbance in the diabetic heart
Fuentes‐Antrás, J., Picatoste, B., Ramírez, E., Egido, J., Tuñón, J., & Lorenzo, Ó. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0173-8 · Cited by 59 · see citing works
Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice
How, O.-J., Larsen, T. S., Hafstad, A. D., Khalid, A. M., Myhre, E. S. P., Murray, A. J., Boardman, N. T., Cole, M. A., Clarke, K., Severson, D. L., et al. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701783281 · Cited by 59 · see citing works
Self-citationRosiglitazone Protects Against Cyclosporine‐Induced Pancreatic and Renal Injury in Rats
Chung, B. H., Li, C., Sun, B., Lim, S. W., Ahn, K. O., Yang, J. H., Choi, Y. H., Yoon, K., Sugawara, A., Ito, S., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00979.x · Cited by 58 · see citing works
Free Radicals and Antioxidants in Inflammatory Processes and Ischemia-Reperfusion Injury
Vajdovich, P. (2008) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2007.11.008 · Cited by 55 · see citing works
Type 2 diabetes, mitochondrial biology and the heart
Sack, M. N. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.001 · Cited by 53 · see citing works
Transportadores de glicose na síndrome metabólica
Machado, U. F., Schaan, B. D., & Seraphim, P. M. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200004 · Cited by 52 · see citing works
Metabolic regulation of sodium–calcium exchange by intracellular acyl CoAs
Riedel, M. J., Baczkó, I., Searle, G. J., Webster, N. J., Fercho, M., Jones, L. S., Lang, J., Lytton, J., Dyck, J. R. B., & Light, P. E. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601321 · Cited by 52 · see citing works
Fonarow, G. C., & Srikanthan, P. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.05.003 · Cited by 52 · see citing works
Palee, S., Weerateerangkul, P., Chinda, K., Chattipakorn, S. C., & Chattipakorn, N. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.070433 · Cited by 51 · see citing works
PPAR-γ activation fails to provide myocardial protection in ischemia and reperfusion in pigs
Xu, Y., Gen, M., Lu, L., Fox, J., Weiss, S. O., Brown, R. D., Perlov, D., Ahmad, H., Zhu, P., Greyson, C., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2004 · Cited by 49 · see citing works
High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury
Salie, R., Huisamen, B., & Lochner, A. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0109-8 · Cited by 49 · see citing works
Peroxisome proliferator‐activated receptors and inflammation: take it to heart
Smeets, P. J. H., Planavila, A., Vusse, G. J., & van Bilsen, M. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01752.x · Cited by 49 · see citing works
Deeks, E. D., & Keam, S. J. (2007) · Drugs · doi:10.2165/00003495-200767180-00008 · Cited by 43 · see citing works
Diep, Q. N., Amiri, F., Benkirane, K., Paradis, P., & Schiffrin, E. L. (2004) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-094 · Cited by 43 · see citing works
Gobal, F. A., Deshmukh, A. J., Shah, S. V., & Mehta, J. L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.027 · Cited by 41 · see citing works
Heart Sphingolipids in Health and Disease
Baranowski, M., & Górski, J. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_3 · Cited by 41 · see citing works
Gender‐dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice
Shimoni, Y., Chuang, M., Abel, E. D., & Severson, D. L. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055590 · Cited by 39 · see citing works
Pælestik, K., Jespersen, N. R., Jensen, R. V., Johnsen, J., Bøtker, H. E., & Kristiansen, S. B. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0628-1 · Cited by 38 · see citing works
Barlaka, E., Galatou, E., Mellidis, K., Ravíngerová, T., & Lazou, A. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12166 · Cited by 37 · see citing works
Metabolic (In)Flexibility of the Diabetic Heart
Larsen, T. S., & Aasum, E. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6083-1 · Cited by 37 · see citing works
Pelletier, A., Tardif, A., Gingras, M., Chiasson, J., & Coderre, L. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9303-7 · Cited by 36 · see citing works
Wilson, K. D., Li, Z., Wagner, R. A., Yue, P., Tsao, P. S., Nestorova, G. G., Huang, M., Hirschberg, D. L., Yock, P. G., Quertermous, T., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002609 · Cited by 36 · see citing works
Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats
Burlá, A. K., Lobato, N. S., Fortes, Z. B., Oigman, W., & Neves, M. F. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.09.012 · Cited by 34 · see citing works
Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?
Goltsman, I., Khoury, E. E., Winaver, J. M., & Abassi, Z. A. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.007 · Cited by 33 · see citing works
Mohamad, H. E., Askar, M. E., & Hafez, M. M. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-4 · Cited by 33 · see citing works
Chen, R., Liang, F.-X., Moriya, J., Yamakawa, J.-I., Takahashi, T., Shen, L., & Kanda, T. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.03.080 · Cited by 31 · see citing works
Pasqua, T., Rocca, C., Giglio, A., & Angelone, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040721 · Cited by 31 · see citing works
Coort, S. L., Coumans, W. A., Bonen, A., Vusse, G. J., Glatz, J. F. C., & Luiken, J. J. F. P. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400426-jlr200 · Cited by 31 · see citing works
PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system?
Palee, S. (2011) · World Journal of Cardiology · doi:10.4330/wjc.v3.i5.144 · Cited by 29 · see citing works
Myocardial fatty acid utilization as a determinant of cardiac efficiency and function
Jaswal, J. S., & Ussher, J. R. (2009) · Clinical Lipidology · doi:10.2217/clp.09.18 · Cited by 29 · see citing works
CINE-MR Imaging of the Normal and Infarcted Rat Heart Using an 11.7 T Vertical Bore MR System
Tyler, D. J., Lygate, C. A., Schneider, J. E., Cassidy, P. J., Neubauer, S., & Clarke, K. J. (2006) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640500451903 · Cited by 28 · see citing works
Self-citationDandona, P., & Aljada, A. (2004) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00259-3 · Cited by 28 · see citing works
The role of PPAR in myocardial response to ischemia in normal and diseased heart
Ravíngerová, T., Adameová, A., Čarnická, S., Nemčeková, M., Kelly, T., Matějíková, J., Galatou, E., Barlaka, E., & Lazou, A. (2011) · General Physiology and Biophysics · doi:10.4149/gpb_2011_04_329 · Cited by 27 · see citing works
ROSIGLITAZONE: POTENTIAL BENEFICIAL IMPACT ON CARDIOVASCULAR DISEASE
Viberti, G. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10441.x · Cited by 27 · see citing works
Palee, S., Weerateerangkul, P., Surinkaew, S., Chattipakorn, S. C., & Chattipakorn, N. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2011.057885 · Cited by 26 · see citing works
Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?
Buckingham, R. E., & Hanna, A. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00700.x · Cited by 26 · see citing works
Self-citation
- Authors
- Sidell, R. J., Cole, M. A., Draper, N. J., Desrois, M., Buckingham, R. E., & Clarke, K.
- Affiliations
- University of Oxford (GB)
- GlaxoSmithKline (United Kingdom) (GB)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2002-04-01
- Volume
- 51
- Issue
- 4
- Pages
- 1110-1117
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2166216264
- Cited by
- 165
- References
- 50
- Citations by year
- 2026: 1 · 2025: 2 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 9 · 2014: 8 · 2013: 9 · 2012: 8
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- British Heart Foundation (PS/02/002/14893)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- rosiglitazone, thiazolidinediones, insulin resistance, obesity, Zucker fatty rats, myocardial ischemia, myocardial ischemia-reperfusion injury, GLUT4, glucose uptake, cardiac contractile function, cardiac hypertrophy, congestive heart failure
- MeSH terms
- Rosiglitazone, Animals, Blood Glucose, Blood Pressure, Body Weight, Heart, Heart Rate, Hypoglycemic Agents, Insulin Resistance, Obesity, Organ Size, Perfusion, Rats, Zucker, Reference Values, Thiazoles, Time Factors, Myocardial Reperfusion, Myocardial Ischemia, Thiazolidinediones, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
